Epizyme reported $-65834000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 2100M 911M
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Amarin AMRN:US $ -13.15M 20.96M
Amgen AMGN:US $ 1884M 1420M
Avrobio Inc AVRO:US $ -32613000 1.23M
Biogen BIIB:US $ 329.2M 119.3M
Bluebird Bio BLUE:US $ -216.82M 24.89M
Cerulean Pharma CERU:US $ -12.67M 3.5M
Daiichi Sankyo 4568:JP Y 27246M 7974M
Eisai 4523:JP Y 4024M 38138M
Epizyme EPZM:US $ -65.83M 1.47M
Exelixis EXEL:US $ 38.2M 57.89M
Gilead Sciences GILD:US $ 2592M 1070M
GlaxoSmithKline GSK:LN 1168M 227M
Glaxosmithkline GSK:US $ 1168M 227M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
Karyopharm Therapeutics KPTI:US $ -51812000 1.77M
Macrogenics MGNX:US $ -52.89M 12.95M
Merk MRK:US $ 4567M 3022M
Mirati Therapeutics MRTX:US $ -80.05M 86.38M
Novartis NOVN:VX SF 2758M 138M
Novartis NVS:US $ 2758M 138M
Pfizer PFE:US $ 8146M 2582M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Seattle Genetics SGEN:US $ -293.85M 209.27M
Spectrum Pharmaceuticals SPPI:US $ -33.08M 17.05M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M
Xencor XNCR:US $ -40.19M 92.44M